Budget Act03/11/2026Medical devices: the budget confirms the payback scheme, with a bill of 12.5 billion for businesses
Planet Life Sciences03/11/2026Johnson & Johnson: the first 50 years in Italia. CEO Murzi: ‘Please allow us to invest further’
Farmindustria03/11/2026Medicines: the budget bill provides for a reduction in payback, but only from 2028. Industry representatives: ‘Immediate action is needed’
The Basel Group27/10/2026Horber (Novartis): ‘We are still investing, but Italia and Europe are losing ground’
The survey27/10/2026Italian pharma sector still only halfway there when it comes to artificial intelligence; there is a shortage of expertise
Advocacy21/10/2026Sanofi: the Patient Council is stepping up efforts to promote the value of innovation and access to treatment
Over-the-counter medicines20/10/2026Self-medication: fewer doctor’s appointments and A&E visits, saving the NHS 3 billion
The CEO of Boehringer Ingelheim20/10/2026‘We manufacture medicines in Italia, but they reach Chinese patients first’
The frontiers of research15/10/2026From HIV to CAR-T: “Here is the model through which Gilead’s research focuses on the science of connections”
Life Sciences and new developments08/10/2026Life sciences: the challenge of moving from ‘egosystems’ to competitive ecosystems
The Cdmo sector06/10/2026Contract manufacturing of medicines: how Italia remains the European leader with a turnover of 4.3 billion
The multinational company05/10/2026Ibsa is once again investing in Lodi: 13 million to boost hyaluronic acid production
Hunter syndrome02/10/2026Italfarmaco and JCR Pharmaceuticals: agreement on a new experimental treatment
Stevanato Group01/10/2026Injectable therapies: self-administration drives innovation in medical devices
The new headquarters 29/09/2026Bayer Italia’s headquarters opens at Mind in Milan, where health becomes an ecosystem
The 11th Egualia Report29/09/2026Affordable medicines, savings of over 2 billion, but cost pressures threaten the sector
Lazio25/09/2026Sanofi is transforming its Anagni site and stepping up the pace of the biotech revolution
Working in the healthcare sector16/09/2026Specialist pharmacies, new contract: pay rises to 270 euros and greater protection
Development16/09/2026Angelini Ventures: 17 million investment in Medical Microinstrument alongside the EIB
The controversy 09/09/2026‘Up to 300 million treatments at risk’: private sector raises the alarm over waiting lists
Pension and healthcare 30/07/2026Pharmacies: how the influx of big money and technological innovation are transforming the sector
The challenge of dementia23/07/2026Alzheimer’s: Lilly reaffirms its commitment to sustainability and patient care
Medical devices07/07/2026Biomedical sector: businesses sound the alarm: ‘We need a new governance structure now’
The Forum26/06/2026The challenges facing the pharmaceutical and life sciences sectors take centre stage at Woma in Milan
Medicines24/06/2026Biosimilars: risks regarding tenders and access to treatment – reviving the Italian model
